Stratos Wealth Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
25,057
-4,714
-16% -$239K 0.01% 760
2026
Q1
$1.59M Sell
29,771
-3,215
-10% -$189K 0.02% 633
2025
Q4
$2.05M Sell
32,986
-3,480
-10% -$215K 0.02% 543
2025
Q3
$2.19M Buy
36,466
+241
+0.7% +$14.7K 0.03% 508
2025
Q2
$2.27M Sell
36,225
-1,909
-5% -$115K 0.03% 464
2025
Q1
$2.3M Sell
38,134
-2,886
-7% -$179K 0.03% 413
2024
Q4
$2.39M Sell
41,020
-459
-1% -$27.3K 0.03% 424
2024
Q3
$2.46M Sell
41,479
-753
-2% -$43K 0.04% 410
2024
Q2
$2.37M Buy
42,232
+291
+0.7% +$16.3K 0.04% 408
2024
Q1
$2.46M Buy
41,941
+8,467
+25% +$478K 0.04% 396
2023
Q4
$1.81M Sell
33,474
-4,886
-13% -$239K 0.03% 441
2023
Q3
$1.86M Buy
38,360
+57
+0.1% +$3.03K 0.04% 390
2023
Q2
$2.16M Buy
38,303
+2,808
+8% +$155K 0.05% 339
2023
Q1
$1.92M Sell
35,495
-8,699
-20% -$463K 0.05% 331
2022
Q4
$2.32M Sell
44,194
-2,220
-5% -$113K 0.06% 312
2022
Q3
$2.19M Sell
46,414
-4,745
-9% -$246K 0.06% 298
2022
Q2
$2.58M Buy
51,159
+386
+0.8% +$21K 0.07% 273
2022
Q1
$3.1M Sell
50,773
-4,501
-8% -$268K 0.07% 261
2021
Q4
$3.64M Sell
55,274
-2,310
-4% -$148K 0.08% 235
2021
Q3
$3.62M Sell
57,584
-1,984
-3% -$127K 0.09% 220
2021
Q2
$3.58M Sell
59,568
-4,398
-7% -$254K 0.09% 227
2021
Q1
$3.52M Sell
63,966
-6,468
-9% -$359K 0.1% 210
2020
Q4
$3.84M Buy
70,434
+12,336
+21% +$645K 0.11% 194
2020
Q3
$2.9M Sell
58,098
-8,634
-13% -$418K 0.1% 215
2020
Q2
$2.94M Buy
66,732
+3,900
+6% +$167K 0.1% 202
2020
Q1
$2.36M Buy
62,832
+2,964
+5% +$125K 0.11% 193
2019
Q4
$2.64M Buy
59,868
+11,052
+23% +$465K 0.1% 207
2019
Q3
$2.01M Buy
48,816
+6,102
+14% +$250K 0.09% 236
2019
Q2
$1.71M Sell
42,714
-1,512
-3% -$57.2K 0.07% 250
2019
Q1
$1.71M Buy
44,226
+12,384
+39% +$450K 0.08% 256
2018
Q4
$1.06M Buy
31,842
+1,854
+6% +$64.2K 0.05% 314
2018
Q3
$1.14M Sell
29,988
-1,518
-5% -$53.9K 0.05% 308
2018
Q2
$1.05M Sell
31,506
-666
-2% -$21.7K 0.05% 351
2018
Q1
$992K Sell
32,172
-390
-1% -$12K 0.04% 372
2017
Q4
$942K Buy
32,562
+3,480
+12% +$100K 0.04% 361
2017
Q3
$810K Buy
29,082
+15,186
+109% +$420K 0.04% 379
2017
Q2
$386K Buy
13,896
+5,418
+64% +$143K 0.02% 540
2017
Q1
$214K Buy
+8,478
New +$206K 0.01% 703

Other funds holding IHI

Stratos Wealth Partners's IHI Position: Q2 2026 in Review

Stratos Wealth Partners reduced its iShares US Medical Devices ETF (IHI) stake by 16% in Q2 2026, selling an estimated $239K and leaving 25,057 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #760.

Stratos Wealth Partners first reported a position in IHI in Q1 2017 and has held it in 38 quarters since. The position peaked at $3.84M in Q4 2020. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Stratos Wealth Partners held 25,057 shares of iShares US Medical Devices ETF worth $1.24M as of Q2 2026.
  • Stratos Wealth Partners sold 4,714 iShares US Medical Devices ETF shares in Q2 2026, an estimated $239K.
  • iShares US Medical Devices ETF made up 0.01% of Stratos Wealth Partners's portfolio in Q2 2026, its #760 holding.
  • Stratos Wealth Partners first reported a position in iShares US Medical Devices ETF in Q1 2017 and has held it in 38 quarters since.
  • Stratos Wealth Partners's iShares US Medical Devices ETF position peaked at $3.84M in Q4 2020.
  • 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.